Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer.
Nikhil K, Chang L, Viccaro K, Jacobsen M, McGuire C, Satapathy SR, Tandiary M, Broman MM, Cresswell G, He YJ, Sandusky GE, Ratliff TL, Chowdhury D, Shah K.
Nikhil K, et al. Among authors: chang l.
Cancer Lett. 2019 Apr 28;448:182-196. doi: 10.1016/j.canlet.2019.01.035. Epub 2019 Feb 1.
Cancer Lett. 2019.
PMID: 30716360
Free PMC article.